Evidence map›Paper›PMID 19460325›Full record

ReviewInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2009

Population biology of the human restricted pathogen, Streptococcus pyogenes.

Debra E Bessen

Abstract readReview
In one paragraph

Review in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Prospective bacterial and fungal sources of hyaluronic acid: A review.Computational and structural biotechnology journal · 2022
    Review
  10. Article
  11. Article
  12. Review
  13. Two zinc-binding domains in the transporter AdcA fromThe Journal of biological chemistry · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Debra E BessenDepartment of Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA. debra_bessen@nymc.edu

Funding

Population genomics of Streptococcus pyogenesR01AI065572 · NIAID · NEW YORK MEDICAL COLLEGE · PI BESSEN, DEBRA E · 2005 to 2009
$1.8M
Tissue-Specific Infection by Group A StreptococciR01AI053826 · NIAID · NEW YORK MEDICAL COLLEGE · PI BESSEN, DEBRA E · 2003 to 2007
$1.3M
EVOLUTION OF GROUP A STREPTOCOCCIR01GM060793 · NIGMS · YALE UNIVERSITY · PI BESSEN, DEBRA E · 2000 to 2004
$1.1M
Tissue-Specific Infection by Group A StreptococciR56AI053826 · NIAID · NEW YORK MEDICAL COLLEGE · PI BESSEN, DEBRA E · 2008 to 2009
$808k
Molecular Evolution of Resistance in Strep. pyogenesR21AI061454 · NIAID · NEW YORK MEDICAL COLLEGE · PI BESSEN, DEBRA E · 2004 to 2005
$429k
NIAID NIH HHS AI053826NIAID NIH HHS AI061454NIAID NIH HHS AI065572NIAID NIH HHS R01 AI053826NIAID NIH HHS R01 AI065572NIAID NIH HHS R21 AI061454NIAID NIH HHS R56 AI053826NIGMS NIH HHS GM060793NIGMS NIH HHS R01 GM060793
6 · The paper itself

Abstract

Streptococcus pyogenes, also referred to as beta-hemolytic group A streptococci, are strictly human pathogens with a global distribution and high prevalence of infection. The organisms are characterized by high levels of genetic recombination, extensive strain diversity, and a narrow habitat. This review highlights many key features of the population genetics and molecular epidemiology of this biologically diverse bacterial species, with special emphasis on ecological subdivisions and tissue-specific infections, strain diversity and population dynamics in communities, selection pressures arising from the specific host immune response and antibiotic exposure, and within-host selection during the course of invasive disease.

Indexed as

Evolution, MolecularAnti-Bacterial AgentsDrug Resistance, BacterialEcologyGenetics, PopulationHumansMolecular EpidemiologyPhylogenySelection, GeneticStreptococcal InfectionsStreptococcus pyogenesAnti-Bacterial Agents

Identifiers

PMID19460325
PMCPMC2685916

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.